Research Only
RETAKLIK 2.0 Retatrutide + Cagrilintide 35mg Total (30mg + 5mg) AQ Pen
This fixed 3mL blend is labelled with 30mg Retatrutide, an investigational GIP/GLP-1/glucagon receptor agonist, and 5mg Cagrilintide, an investigational long-acting amylin analogue. The compounds have separate research programmes; no study of this fixed Genovare blend is supplied. No batch-specific independent report is linked, so component identity, quantity and purity are unverified.
Compound: Retatrutide + Cagrilintide
Catalogue strength: 35 mg total (30 mg + 5 mg)
Format: Aqueous pre-filled pen
Storage: Follow the Genovare package label.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
What Is Included
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare · Pre-Filled Pen · Premixed Aqueous
RETAKLIK 2.0 Retatrutide + Cagrilintide 35mg Total (30mg + 5mg) AQ Pen
35 mg total (30 mg + 5 mg) · Aqueous pre-filled pen
AED 1,200
Out of stock
- Sold by
- Remy Peptides
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | Retatrutide + Cagrilintide |
| Catalogue strength | 35 mg total (30 mg + 5 mg) |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |